Genoptix
Company

Last deal

Amount

Private Equity

Stage

01.01.2010

Date

3

all rounds

$27.99M

Total amount

date founded

Financing round

General

About Company
Genoptix is a provider of cancer-focused genetic testing and develops diagnostic tests.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1999

Number of employees

Company Type

For Profit

Last funding type

Private Equity

IPO status

Private

Description

With almost 20 years of experience, Genoptix has diagnosed over 1.7 million patients and offers a broad menu of testing solutions, from pathology expertise to next-generation testing, to enable confident decisions in optimizing precision medicine. The company sets a higher standard of quality, from science to service, and is dedicated to advancing positive outcomes in oncology through innovation, quality, and service.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
GenePath Dx

GenePath Dx

GenePath Dx is a diagnostics company that provides advanced molecular diagnostic techniques to the medical and healthcare communities.

Sector

Medical Equipment and Services

Subsector

Medical Services

Location

Pune, Maharashtra, India

total rounds

1
MNG Laboratories

MNG Laboratories

MNG Laboratories provides molecular and neurochemical genetic testing for inherited neurological and mitochondrial disorders.

Sector

Medical Equipment and Services

Subsector

Medical Services

Keywords

Health Care, Biotechnology, Medical

Location

Atlanta, GA, USA

total rounds

1
4bases

4bases

4bases provides clinically-validated solutions to healthcare professionals who rely on diagnostic genetic tests.

Sector

Medical Equipment and Services

Subsector

Medical Services

Keywords

Health Care, Biotechnology, Medical

Location

Manno, Switzerland
GenPath

GenPath

GenPath, a division of BioReference Laboratories, Inc. provides diagnostic oncology and testing solutions for cancer patients.

Sector

Medical Equipment and Services

Subsector

Medical Services

Location

Elmwood Park, NJ, USA
M&A Details
1

Transaction name

Acquired by

NeoGenomics

announced date

23.10.2018

Financials

Funding Rounds
4
3

Number of Funding Rounds

$27.99M

Money Raised

Their latest funding was raised on 01.01.2010. Their latest investor Hudson River Capital Partners. Their latest round Private Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
01.01.2010
1
09.08.2005
$17.3M
24.09.2004
3
$3M
Co-Investors
Investors
4
0

Number of lead investors

4

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series B, Series C
No
Series B, Series C
Hudson River Capital Partners

Hudson River Capital Partners

Hudson River Capital Partners is a private investment firm focused on healthcare businesses.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

Irvington, NY, USA

count Of Investments

19

count Of Exists

7
Alliance Technology Ventures

Alliance Technology Ventures

Alliance Technology Ventures is an investment firm that focuses on the semiconductor, communications, and life sciences industries.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Venture Capital, Financial Services

Location

Sarasota, FL, USA

count Of Investments

32

count Of Exists

11
Enterprise Partners

Enterprise Partners

Enterprise Partners is a venture capital firm that invests in Southern California businesses.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

La Jolla, San Diego, CA, USA

count Of Investments

94

count Of Exists

29
Acquisitions
2
Acquiree Name 
Date 
Price 
Acquisition Name 
Rosetta Genomics acquired by Genoptix

Rosetta Genomics acquired by Genoptix

acquirer

Genoptix
Genoptix

date

15.12.2017

type

Acquisition

price

$10M
Rosetta Genomics

Rosetta Genomics

Rosetta Genomics uses microRNA-based diagnostics to address unmet needs in cancer and cardiovascular diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Philadelphia, PA, USA

total rounds

3

total raised

$5.99M
HistoRx acquired by Genoptix

HistoRx acquired by Genoptix

acquirer

Genoptix
Genoptix

date

01.09.2012

type

Acquisition
HistoRx

HistoRx

HistoRx develops tissue-based diagnostic products for targeted patient treatment.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New Haven, CT, USA

total rounds

5

total raised

$15.26M

People

Founders
3

Tina Nova

organization founded

1

Tina Nova

Tina Nova

Tina S. Nova is the President and CEO at Decipher Biosciences.

current job

Genoptix
Genoptix

organization founded

1

Tina Nova

Sadik Esener
Sadik Esener

Sadik Esener

Sadik Esener joined the UCSD faculty in 1987, after receiving his Ph.D. in Applied Physics and Electrical Engineering from UCSD the same year. He leads UCSD’s OptoElectronic Computing Group, and is the director of: the DARPA-funded multi-university Center for Chips with Heterogenously Integrated Photonics (CHIPS); the 3D-Opto-Electronic Stacked Processors industry/university consortium; and the Fast Read-out Optical Storage (FROST) Industry consortium. He has authored more than 100 journal publications and 200 conference abstracts. Esener is a member of IEEE, OSA, and SPIE, and co-founded San Diego-based Nanogen, Optical Micro-Machines, Parallel Solutions, Genoptix, and Call/Recall Inc.Sadik Esener joined the UCSD faculty in 1987, after receiving his Ph.D. in Applied Physics and Electrical Engineering from UCSD the same year. He leads UCSD’s OptoElectronic Computing Group, and is the director of: the NANOTUMOR CENTER for cancer nanotechnology at the UCSD Moores Cancer center, and co-director of the Center for Nanomedicine and Engineering in IEM. Previously he served as the director of DARPA-funded multi-university Center for Chips with Heterogenously Integrated Photonics (CHIPS); the 3D-Opto-Electronic Stacked Processors industry/university consortium; and the Fast Read-out Optical Storage (FROST) Industry consortium. He has authored more than 150 journal publications and 250 conference abstracts. Esener is a fellow of OSA and a member of IEEE, and SPIE, and co-founded San Diego-based Nanogen, Genoptix, SONRGY, Optical Micro-Machines, Ziva, and Call/Recall Inc.

current job

Genoptix
Genoptix

organization founded

1

Sadik Esener

Employee Profiles
126

Shiloh Guerrero

Senior associate scientist

Allison Steinkamp

Executive administrator

Courtney Hunter

Contracts manager, legal

Panisa Pochanard

Clinical genetic molecular biologist scientist trainee

Frederick Fletcher

Svp-operations

Ken Wey

Senior lims application manager

Facmg Li Cheng

Associate director, cytogenetics

Jerry Wang

Associate scientist

Activity

Recent News
0